Gallant, Karen
21  results:
Search for persons X
?
1

Barriers and enablers to influenza vaccination uptake in ad..:

Gallant, Allyson J ; Flowers, Paul ; Deakin, Karen...
https://strathprints.strath.ac.uk/77173/7/Gallant_etal_PH_2021_Barriers_and_enablers_to_influenza_vaccination_uptake_in_adults_with_chronic_respiratory_conditions.pdf.  , 2023
 
?
2

A mixed methods study of seasonal influenza vaccine hesitan..:

Williams, Lynn ; Deakin, Karen ; Gallant, Allyson...
https://strathprints.strath.ac.uk/75851/7/Williams_etal_IORV_2021_A_mixed_methods_study_of_seasonal_influenza_vaccine_hesitancy.pdf.  , 2021
 
?
3

Managing work flow in high enrolling trials: The developmen..:

David Pogorzelski ; Uyen Nguyen ; Paula McKay...
http://www.sciencedirect.com/science/article/pii/S2451865421000326.  , 2021
 
?
4

Implementing stakeholder engagement to explore alternative ..:

Guillermo Pechero, Jr., MD ; Branden Pfaff ; Mayank Rao...
http://www.sciencedirect.com/science/article/pii/S2451865421000880.  , 2021
 
?
6

Towards intervention development to increase the uptake of ..:

Williams, Lynn ; Gallant, Allyson J ; Rasmussen, Susan...
https://strathprints.strath.ac.uk/73550/7/Williams_etal_BJHP_2020_Towards_intervention_development_to_increase_the_uptake_of_COVID_19_vaccination_among.pdf.  , 2020
 
?
8

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
9

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
10

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
11

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
12

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
13

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543.  , 2019
 
?
 
1-15